UK AD-SMART platform trial speeds Alzheimer disease treatment discovery by testing multiple repurposed drugs at once across NHS sites, aiming to protect memory and quality of life.
|Slideshows|May 7, 2015
Monthly Roundup: Top 6 Psychiatry Features in April
Author(s)Psychiatric Times Editors
Editors' choices of noteworthy psychiatry-related news, blogs, CMEs, research studies, cases, and videos from around the Web.
Advertisement
 The following is a list of editors' choices of noteworthy psychiatry-related articles published in April 2015.Sources:Taking a Science-Informed Approach to Medical MarijuanaTips, Cautions, and Successes in Treating Bipolar Patients With LithiumAutism: Where Do We Go From Here?Alcoholics Anonymous and the Challenge of Evidence-Based MedicineAyahuasca Psychedelic Tested for DepressionAdult Mental Health Consequences of Peer Bullying and Maltreatment in ChildhoodTo view the slides in PDF format, click here.For last month's Roundup, click here.
Advertisement
Related to this article
When an antidepressant seems to stop working, the patient’s deterioration is real. The explanation may be less certain.
The evidence points toward an overall protective effect in adult cohorts and no increase in completed suicide in younger populations.
A psychiatry resident and APA Diversity Leadership Fellow explains how social history, open talk about stigma, and bilingual videos can widen access to care.
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
Explore evolving ethical challenges of long-acting injectable antipsychotics, weighing relapse prevention against coercion, stigma, incentives, and racial equity in clinical practice.
Neurocrine launches a phase 2 trial of once-daily NBI-'567, testing a selective muscarinic agonist to boost cognition in mild to moderate Alzheimer disease.
Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.
Advertisement
Advertisement
Trending on Psychiatric Times
1
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
2
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
3
Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5